Profitelligence Profitelligence · Filing Ledger Open A research →

Form 8-K · Current Report · Filed 2026-03-06

Agilent Announces Retirement of Vice President, Corporate Controller and Principal Accounting Officer

Agilent Technologies, Inc. announced on March 5, 2026, that Rodney Gonsalves, Vice President, Corporate Controller, and Principal Accounting Officer, will retire in January 2027. The retirement is not related to any disagreements on accounting practices, financial statements, internal controls, or operations, providing ample time for a transition. This announcement was made to ensure a smooth succession plan and for Mr. Gonsalves to assist in the transition of his duties.

Filer
Agilent Technologies Inc. A · NYSE
Filed
Accession
0001193125-26-096487
CIK
0001090872
Signal
Medium impactHealthcare

Items reported

Item events

Reported Item

CAO Resignation

Market reaction

Close before filing

$118.11

Next session

-1.2%

Since filing

+17.2%

Latest close

$138.37

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from A reporting the same item, with the next session's move:

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another A filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts